Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep;29(9):6029-6030.
doi: 10.1245/s10434-022-11878-6. Epub 2022 May 18.

ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma

Anne E O'Shea  1 , Elizabeth L Carpenter  2 , Daniel W Nelson  3 , Timothy J Vreeland  2
Affiliations
Comment

ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma

Anne E O'Shea et al. Ann Surg Oncol. 2022 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Sugimoto M, Takahashi N, Farnell MB, et al. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: a propensity matching and intention-to-treat analysis. J Surg Oncol. 2019;120(6):976–84. https://doi.org/10.1002/jso.25681 . - DOI - PubMed
    1. Versteijne E, Suker M, Groothuis K, et al. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial. J Clin Oncol. 2020;38(16):1763–73. https://doi.org/10.1200/JCO.19.02274 . - DOI - PubMed - PMC
    1. Hu Q, Wang D, Chen Y, Li X, Cao P, Cao D. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma. Radiat Oncol. 2019;14(1):120. https://doi.org/10.1186/s13014-019-1330-0 . - DOI - PubMed - PMC
    1. O’Shea AE, Kemp Bohan PM, Carpenter EL, et al. Downstaging of pancreatic adenocarcinoma with either neoadjuvant chemotherapy or chemoradiotherapy improves survival. Ann Surg Onocol. 2022. https://doi.org/10.1245/s10434-022-11800-0 . - DOI
    1. Katz MHG, Shi Q, Meyers JP, et al. Alliance A021501: preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas. J Clin Oncol. 2021;39(3_suppl):377–377. https://doi.org/10.1200/JCO.2021.39.3_suppl.377 . - DOI